Hepatocellular Carcinoma Is Associated With an Increased Risk of Hepatitis B Virus Recurrence After Liver Transplantation (original) (raw)

Association Between Hepatitis B and Hepatocellular Carcinoma Recurrence in Patients Undergoing Liver Transplantation

Deniz Sigirli

Transplantation Proceedings, 2008

View PDFchevron_right

Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation

Munira Hussain

Liver Transplantation, 2007

View PDFchevron_right

Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation

Francisco Durazo

Liver Transplantation, 2009

View PDFchevron_right

Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence. The European Cooperative Study Group on Liver Cancer and Transplantation

Ferruccio Bonino

Liver, 1996

View PDFchevron_right

Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study

Steven-huy Han

Clinical Transplantation, 2010

View PDFchevron_right

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis

Kazuhide Yamamoto, Fusao Ikeda, Y. Iwasaki, Ryuichi Yoshida, Satoshi Hirohata

Hepatology International, 2011

View PDFchevron_right

Evaluation of Impact of Serial Hepatitis B Virus DNA Levels on Development of Hepatocellular Carcinoma

Vincent Wong

Journal of Clinical Microbiology, 2009

View PDFchevron_right

Significance of HBV DNA in the Hepatic Parenchyma from Patients with Non-B, Non-C Hepatocellular Carcinoma

Hidetoshi Ota

World Journal of Surgery, 2006

View PDFchevron_right

Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis

Man-fung Yuen

Clinical Gastroenterology and Hepatology, 2019

View PDFchevron_right

HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis

Valérie Delvart, Cyrille Feray

Hepatology, 2003

View PDFchevron_right

Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma

Chien-wei Su, Jaw-ching Wu

Journal of Hepatology, 2009

View PDFchevron_right

High Viremia, Prolonged Lamivudine Therapy and Recurrent Hepatocellular Carcinoma Predict Posttransplant Hepatitis B Recurrence†

Hahn Lee

American Journal of Transplantation, 2010

View PDFchevron_right

The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy

Hao-jan Lei, Chien-wei Su

PLoS ONE, 2013

View PDFchevron_right

Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues

Ravat Panvichian

Medical Oncology, 2018

View PDFchevron_right

INFLUENCE OF ANTIVIRAL THERAPY IN THE NATURAL HISTORY OF HEPATITIS B VIRUS RECURRENCE AFTER LIVER TRANSPLANTATION: RETROSPECTIVE STUDY OF 14 CASES

Javier de Haro

Transplantation, 1999

View PDFchevron_right

Virologic and Biochemical Changes and Prognosis after Liver Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

Shigekazu Takemura

Digestive Surgery, 2001

View PDFchevron_right

Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma

Man-fung Yuen

Hepatology, 2011

View PDFchevron_right

Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues?

Jaime Guardia

Annals of hepatology

View PDFchevron_right

Persistent Risk for HBV Associated Hepatocellular Carcinoma in spite of Sustained and Successful Viral Suppression: The Need for Drugs for HBV Cure

Hie-won Hann

Cancer Studies

View PDFchevron_right

Hepatitis B virus related hepatocellular carcinoma: chronicity of infection - the opening to different pathways of malignant transformation?

Cem Kalayci

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1990

View PDFchevron_right

Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Long After Achieving Hbsag Seroconversion: A Need for an Improved Hepatitis B Virus DNA Assay

Hie-won Hann

Clinical microbiology, 2012

View PDFchevron_right

Case Report Open Access Clinical Microbiology: Open Access Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Long After Achieving Hbsag Seroconversion: A Need for an Improved Hepatitis B Virus DNA Assay

Hie-won Hann

2016

View PDFchevron_right

Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation

Ryosuke Tateishi

2011

View PDFchevron_right

Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection

G. Squadrito, Irene Cacciola

Hepatology, 2000

View PDFchevron_right

Real-time quantitation of hepatitis B virus (HBV) DNA in tumorous and surrounding tissue from patients with hepatocellular carcinoma

Elisabetta Cariani

Journal of Medical Virology, 2002

View PDFchevron_right

Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis

Tania Guenci, Marco Ciotti

Digestive and Liver Disease, 2010

View PDFchevron_right

Effects of Genomic Changes in Hepatitis B Virus on Postoperative Recurrence and Survival in Patients with Hepatocellular Carcinoma

Priya Mathews

Annals of Surgical Oncology, 2013

View PDFchevron_right

Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels

Juinn Kam

JAMA surgery, 2014

View PDFchevron_right